Swiss Life Asset Management’s Eli Lilly LLY Stock Holding History

Swiss Life Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429M	Buy	357,284 +18,865	+6%	+$19.3M	1.77%	9
2026 Q1	$311M	Buy	338,419 +30,135	+10%	+$30.6M	1.52%	11
2025 Q4	$331M	Buy	308,284 +6,533	+2%	+$6.25M	1.69%	10
2025 Q3	$230M	Buy	301,751 +14,566	+5%	+$10.8M	1.2%	13
2025 Q2	$224M	Buy	287,185 +66,790	+30%	+$51.9M	1.32%	12
2025 Q1	$182M	Buy	220,395 +24,195	+12%	+$20.1M	1.32%	15
2024 Q4	$151M	Buy	196,200 +54,173	+38%	+$44.9M	1.12%	14
2024 Q3	$126M	Sell	142,027 -2,343	-2%	-$2.11M	1.43%	10
2024 Q2	$131M	Buy	144,370 +19,472	+16%	+$15.6M	1.54%	11
2024 Q1	$97.2M	Sell	124,898 -12,438	-9%	-$8.85M	1.35%	11
2023 Q4	$80.1M	Buy	137,336 +3,830	+3%	+$2.24M	0.96%	14
2023 Q3	$71.7M	Buy	133,506 +1,338	+1%	+$689K	1.11%	10
2023 Q2	$62M	Buy	132,168 +13,048	+11%	+$5.47M	0.92%	11
2023 Q1	$40.9M	Sell	119,120 -45,384	-28%	-$15.3M	0.62%	27
2022 Q4	$60.3M	Sell	164,504 -4,203	-2%	-$1.49M	1.01%	12
2022 Q3	$54.6M	Buy	168,707 +1,359	+0.8%	+$431K	0.94%	11
2022 Q2	$54.4M	Sell	167,348 -3,770	-2%	-$1.13M	0.88%	13
2022 Q1	$48.9M	Sell	171,118 -3,343	-2%	-$860K	0.69%	23
2021 Q4	$48.2M	Sell	174,461 -7,101	-4%	-$1.8M	0.63%	22
2021 Q3	$41.9M	Sell	181,562 -25,386	-12%	-$6.27M	0.58%	32
2021 Q2	$43.1M	Buy	206,948 +6,388	+3%	+$1.28M	0.44%	32
2021 Q1	$37.5M	Sell	200,560 -267	-0.1%	-$52.2K	0.54%	29
2020 Q4	$33.9M	Sell	200,827 -162,662	-45%	-$24.3M	0.5%	37
2020 Q3	$53.8M	Buy	363,489 +10,971	+3%	+$1.7M	0.8%	23
2020 Q2	$57.9M	Buy	352,518 +5,391	+2%	+$828K	0.93%	20
2020 Q1	$48.2M	Buy	347,127 +86,457	+33%	+$11.9M	0.92%	19
2019 Q4	$34.3M	Sell	260,670 -175,295	-40%	-$20.3M	0.65%	35
2019 Q3	$48.7M	Sell	435,965 -81,264	-16%	-$9.05M	0.64%	38
2019 Q2	$57.3M	Buy	517,229 +55,675	+12%	+$6.56M	0.69%	36
2019 Q1	$59.9M	Buy	461,554 +199,404	+76%	+$24.2M	0.76%	31
2018 Q4	$30.3M	Buy	262,150 +11,493	+5%	+$1.28M	0.62%	47
2018 Q3	$26.9M	Sell	250,657 -15,989	-6%	-$1.6M	0.36%	76
2018 Q2	$22.8M	Buy	266,646 +40,495	+18%	+$3.33M	0.34%	84
2018 Q1	$17.5M	Buy	226,151 +172,094	+318%	+$13.9M	0.31%	99
2017 Q4	$4.57M	Buy	54,057 +37,567	+228%	+$3.2M	0.1%	128
2017 Q3	$1.41M	Buy	16,490 +1,105	+7%	+$90.6K	0.04%	254
2017 Q2	$1.27M	Buy	15,385 +5,076	+49%	+$414K	0.03%	263
2017 Q1	$868K	Sell	10,309 -26,528	-72%	-$2.12M	0.02%	326
2016 Q4	$2.71M	Buy	36,837 +7,881	+27%	+$587K	0.09%	141
2016 Q3	$2.32M	Buy	+28,956	New	+$2.32M	0.08%	135
2016 Q2	–	Sell	-12,824	Closed	-$923K	–	353
2016 Q1	$923K	Sell	12,824 -5,977	-32%	-$452K	0.04%	198
2015 Q4	$1.58M	Sell	18,801 -8,776	-32%	-$728K	0.07%	116
2015 Q3	$2.31M	Buy	27,577 +16,086	+140%	+$1.36M	0.11%	108
2015 Q2	$959K	Sell	11,491 -4,276	-27%	-$326K	0.03%	139
2015 Q1	$1.15M	Buy	+15,767	New	+$1.12M	0.05%	145

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Swiss Life Asset Management's LLY Position: Q2 2026 in Review

Swiss Life Asset Management increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $19.3M and bringing the position to 357,284 shares worth $429M. The position accounts for 1.77% of the portfolio, ranked #9.

Swiss Life Asset Management first reported a position in LLY in Q1 2015 and has held it in 45 quarters since. 3,701 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Swiss Life Asset Management held 357,284 shares of Eli Lilly worth $429M as of Q2 2026.
Swiss Life Asset Management bought 18,865 Eli Lilly shares in Q2 2026, an estimated $19.3M.
Eli Lilly made up 1.77% of Swiss Life Asset Management's portfolio in Q2 2026, its #9 holding.
Swiss Life Asset Management first reported a position in Eli Lilly in Q1 2015 and has held it in 45 quarters since.
3,701 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.